Tengion, Inc. (TNGNQ)

Market Cap	40.00 -99.9%
Revenue (ttm)	n/a
Net Income	-64.43M
EPS	-3.89
Shares Out	40.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	17,745
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	60.16
RSI	43.37
Earnings Date	n/a

About Tengion

Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 26
• Stock Exchange: OTCMKTS
• Ticker Symbol: TNGNQ